We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601375:SSECentral China Securities Co Ltd Class A Analysis

Data as of 2026-06-04 - not real-time

CN¥3.97

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Central China Securities is trading near its recent support level, with the short‑term moving average just below the medium‑term average, signaling a modest bearish bias. The relative strength index sits in the middle range, suggesting neither extreme oversold nor overbought conditions, while the MACD histogram has turned positive, hinting at a potential short‑term rebound amid rising volume.
Fundamentally, the firm delivers strong revenue growth and robust operating margins, supported by ample cash reserves that more than cover its debt obligations. However, the price‑earnings multiple is substantially higher than the sector average, and the dividend yield is modest, though the payout ratio and cash position point to sustainability. A discounted cash‑flow model implies a valuation far above the current market price, indicating a pronounced undervaluation. Risks stem from sector‑specific regulatory scrutiny and the broader Chinese market environment, but the stock’s low beta and solid liquidity mitigate market‑wide concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical indicators show mixed signals with bearish trend but bullish MACD histogram
  • Price is near support and volatility is elevated
  • Increasing volume suggests potential short‑term buying pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Strong cash position relative to debt and consistent revenue growth
  • Sustainable dividend despite modest yield

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term undervaluation provides upside potential
  • High operating margins and stable profitability
  • Low beta and solid liquidity reduce market risk over time

Key Metrics & Analysis

Financial Health

Revenue Growth34.70%
Profit Margin25.03%
P/E Ratio36.1
ROE3.58%
ROA0.96%
Debt/Equity130.24
P/B Ratio1.3
Op. Cash FlowCN¥7.1B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI46.3
SupportCN¥3.86
ResistanceCN¥4.15
MA 20CN¥4.01
MA 50CN¥4.01
MA 200CN¥4.34
MACDBullish
VolumeIncreasing
Fear & Greed Index91.59

Valuation

Fair ValueCN¥42.91
GradeUndervalued
TypeValue
Dividend Yield0.61%

Risk Assessment

Beta0.40
Volatility20.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.